APEX1 and neoplasm: We investigated the immunohistochemical levels of APEX1 in cancer and paracancerous tissues of 20 patients with pathologically confirmed LUAD and confirmed that the APEX1 level in tumor tissue was higher than that in paracancerous tissue, which is in line with other studies reported (Gu et al., 2013; Wei et al., 2016).